- Aktuelle Seite:
-
Home
-
Begleitkrankheiten
-
HIV
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.
The Association of Memory Disorders and Chronic HIV Disease in the Antiretroviral Therapy Era - A Systematic Literature Review
E Ripamonti; M Clerici
HIV Medicine. 2020;21(1):9-20.
https://www.medscape.com/viewarticle/922726
HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta‐analysis and trend analysis.
Rahimi, J., Gholami, J., Amin‐Esmaeili, M., Fotouhi, A., Rafiemanesh, H., Shadloo, B., and Rahimi‐Movaghar, A. ( 2020)
Addiction, doi.org/10.1111/add.14853.
Abstract
https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14853?campaign=wolearlyview
No excuses left to delay opioid agonist treatment roll-out.
Malyuta R, Krausz RM.
Lancet HIV. 2019 Dec 23. pii: S2352-3018(19)30409-6. doi: 10.1016/S2352-3018(19)30409-6.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30409-6/fulltext
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.
Dolengevich-Segal H, Gonzalez-Baeza A, Valencia J, Valencia-Ortega E, Cabello A, Tellez-Molina MJ, et al. (2019)
PLoS ONE 14(12): e0220272. doi.org/10.1371/journal.pone.0220272
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0220272
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C, Horth R, Boothe M, Sathane I, Young P, Chitsondzo Langa D, Condula M, Ricardo H, Dengo Baloi L, Cummings B, Schaad N, Gouveia L, Teodoro E, Raymond HF.
BMC Infect Dis. 2019 Dec 2;19(1):1022. doi: 10.1186/s12879-019-4655-2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889180/
People who inject drugs (PWID) and HIV/aids cases in Mexico City: 1987-2015.
Romero Mendoza M, Meza-Mercado D, Martínez-Martínez R, Magis-Rodríguez C, Ortiz Castro A, Medina-Mora ME.
Subst Abuse Treat Prev Policy. 2019 Dec 23;14(1):59. doi: 10.1186/s13011-019-0246-x.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929422/
Perceived need, barriers to and facilitators of mental health care among HIV-infected PWID in Hanoi, Vietnam: a qualitative study.
Nguyen MX, Go VF, Bui QX, Gaynes BN, Pence BW.
Harm Reduct J. 2019 Dec 26;16(1):74. doi: 10.1186/s12954-019-0349-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933924/
Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.
Fanucchi L, Springer SA, Korthuis PT.
Curr HIV/AIDS Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11904-019-00436-7.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420833/
Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence.
Bobashev G, Mars S, Murphy N, Dreisbach C, Zule W, Ciccarone D (2019)
PLoS ONE 14(12): e0215042. doi.org/10.1371/journal.pone.0215042
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215042
Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.
Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O'Grady KE.
Addict Sci Clin Pract. 2019 Dec 2;14(1):45. doi: 10.1186/s13722-019-0172-2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886176/
A client-centered relational framework on barriers to the integration of HIV and substance use services: a systematic review.
Pinto, R.M., Chen, Y. & Park, S.(.E.
Harm Reduct J 16, 71 (2019) doi:10.1186/s12954-019-0347-x
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0347-x
Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
Watson CW, Paolillo EW, Morgan EE, Umlauf A, Sundermann EE, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Grant I.
J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):56-64. doi: 10.1097/QAI.0000000000002211.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31809361
Highest-Ever Funding Allocations Announced to Fight AIDS, TB and Malaria
GENEVA − Following a record-breaking Replenishment in October 2019, the Global Fund today announced its largest-ever funding allocations for eligible countries to fight AIDS, tuberculosis and malaria and build systems for health over the next three years. (Global Fund, Schweiz, 19.12.2019)
https://www.theglobalfund.org/en/news/2019-12-18-highest-ever-funding-allocations-announced-to-fight-aids-tb-and-malaria/
Anwender der Präexpositionsprophylaxe erkranken in Metaanalyse häufig an anderen sexuell übertragbaren Erkrankungen
London – Die Präexpositionsprophylaxe (PrEP), die Menschen mit hohem Infektionsrisiko vor einer HIV-Infektion schützen kann, verleitet viele Anwender offenbar, den Schutz vor anderen sexuell übertragbaren Erkrankungen (STD) zu vernachlässigen. Nach einer Metaanalyse in JAMA (2019; 2: e1917134) infizieren sich bereits in den ersten 3 Monaten der PrEP 3/4 der Anwender mit Chlamydien, Gonokokken oder Treponema pallidum. (aerzteblatt.de, 16.12.2019)
https://www.aerzteblatt.de/nachrichten/108231/Anwender-der-Praeexpositionsprophylaxe-erkranken-in-Metaanalyse-haeufig-an-anderen-sexuell-uebertragbaren-Erkrankungen
Drug addiction and HIV in Ukraine
Burki, Talha
The Lancet Infectious Diseases, Volume 19, Issue 12, 1297
Abstract
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30638-3/fulltext
Deutschland. Zahl der HIV-Neuinfektionen leicht gesunken
Berlin – Im vergangenen Jahr haben sich weniger Menschen in Deutschland mit HIV infiziert. Nach einer Schätzung des Robert-Koch-Instituts (RKI) liegt die Zahl der Neuinfektionen bundesweit bei 2.400. Das seien hundert Fälle weniger als im Jahr zuvor, teilte das RKI heute mit Blick auf den Welt-Aids-Tag am 1. Dezember mit. (aerzteblatt.de, 14.11.2019)
https://www.aerzteblatt.de/nachrichten/107416/Zahl-der-HIV-Neuinfektionen-leicht-gesunken
Willkommen im European HIV/AIDS Archive der Humboldt-Universität zu Berlin!
Das European HIV/AIDS Archive eröffnet einen Raum, Erinnerungen an das Leben mit HIV/AIDS, das zivilgesellschaftliche Engagement und AIDS-Politiken in Europa zu bewahren, Geschichten zu teilen und aus der Vielstimmigkeit zu lernen. Kern der Sammlung sind Oral-History-/Zeitzeug*innen-Interviews zur Geschichte und Gegenwart des individuellen, gesellschaftlichen und politischen Umgangs mit HIV/AIDS. Oral Histories ermöglichen eine lebendige und multi-perspektivische Erinnerung. Das Archiv versteht sich als Ergänzung und Erweiterung bereits in einzelnen europäischen Ländern existierender Sammlungen zu HIV/AIDS. Die Sammlung beinhaltet Video- und Audiointerviews mit Menschen, die mit HIV/AIDS leben, Aktivist*innen, Mitarbeiter*innen von Hilfsorganisationen, Politiker*innen, Beschäftigten des Gesundheitswesens und Künstler*innen zu Themen wie Sexarbeit, Drogen, Migration, Gefängnis, LSBTI-Rechten oder queeren Politiken. Diese werden durch Verzeichnisse von Kunstwerken und politischen Dokumenten ergänzt. (Humboldt Universität, Berlin, November 2019)
https://rs.cms.hu-berlin.de/ehaa/pages/home.php
Stigma reduction interventions in people living with HIV to improve health-related quality of life.
Andersson GZ, Reinius M, Eriksson LE, Svedhem V, Esfahani FM, Deuba K, Rao D, Lyatuu GW, Giovenco D, Ekström AM.
Lancet HIV. 2019 Nov 22. pii: S2352-3018(19)30343-1. doi: 10.1016/S2352-3018(19)30343-1.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30343-1/fulltext
The global burden of HIV and prospects for control
Pandey, Abhishek et al.
The Lancet HIV, Volume 6, Issue 12, e809 - e811
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30230-9/fulltext
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
Frank, Tahvi D et al.
The Lancet HIV, Volume 6, Issue 12, e831 - e859
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30196-1/fulltext
Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial.
Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, Korthuis PT.
BMC Health Serv Res. 2019 Nov 21;19(1):862. doi: 10.1186/s12913-019-4721-x.
https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-4721-x
The Effects of Opioids on HIV Neuropathogenesis.
Murphy A, Barbaro J, Martínez-Aguado P, Chilunda V, Jaureguiberry-Bravo M, Berman JW.
Front Immunol. 2019 Oct 18;10:2445. doi: 10.3389/fimmu.2019.02445.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813247/
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
Zuckerman AD, Douglas A, Whelchel K, Choi L, DeClercq J, Chastain CA.
PLoS One. 2019 Nov 21;14(11):e0225434. doi: 10.1371/journal.pone.0225434.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0225434
Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany.
Christensen S, Wolf E, Altevers J, Diaz-Cuervo H.
PLoS One. 2019 Nov 6;14(11):e0224279. doi: 10.1371/journal.pone.0224279.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224279
Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
Mburu G, Chhoun P, Chann N, Tuot S, Mun P, Yi S.
Subst Abuse Treat Prev Policy. 2019 Oct 17;14(1):42. doi: 10.1186/s13011-019-0232-3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798405/
Interpersonal Violence Syndemics and Co-Occurring Epidemics: Preventing Violence in the Context of Opioid Misuse, Suicide, Social Disparities, and HIV: Proceedings of a Workshop—in Brief.
National Academies of Sciences, Engineering, and Medicine. 2019.
Washington, DC: The National Academies Press. doi.org/10.17226/25634.
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin M-A, Poizot-Martin I, et al. (2019)
PLoS ONE 14(1): e0211286. doi.org/10.1371/journal.pone.0211286
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211286
HIV: Mikrozephalie durch pränatale Exposition mit Efavirenz
Boston – Nicht an HIV erkrankte Kinder, deren HIV-positive Mütter während der Schwangerschaft mit dem antiretroviralen Wirkstoff Efavirenz behandelt wurden, wiesen in einer prospektiven Kohortenstudie 2 bis 2,5-mal häufiger als andere Kinder einen zu kleinen Kopfumfang auf. Die in Lancet HIV (2019; DOI: 10.1016/S2352-3018(19)30340-6) publizierte Studie bestätigt die Teratogenität des häufig eingesetzten Wirkstoffs. (aerzteblatt.de, 19.11.2019)
EACS Guidelines version 10.0 (Nov 2019)
These Guidelines were developed by the European AIDS Clinical Society (EACS), a not-for-profit organisation, whose mission is to promote excellence in standards of care, research and education in HIV infection and related co-infections, and to actively engage in the formulation of public health policy, with the aim of reducing the HIV disease burden across Europe.
The EACS Guidelines were first published in 2005, and are currently available in print, online as a pdf, a web edition (new for 2019) and as a free mobile App for both iOS and Android devices. The Guidelines are translated into several different languages and are formally revised at least annually for the electronic version and biennially for the printed version. The electronic version can, however, be updated at any time if the panels consider it necessary.
The aim of the EACS Guidelines is to provide easily accessible and comprehensive recommendations to clinicians involved in the care of people living with HIV (PLWH).
The EACS Guidelines cover a relatively large and diverse area geographically, with different national levels of access to care. As a natural consequence, the Guidelines aim to cover a relatively wide range of recommendations as opposed to the often more uniform national guidelines.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases. (European AIDS Clinical Society, November 2019)
https://eacs.sanfordguide.com/
Rapid initiation of antiretroviral therapy in those with newly diagnosed HIV infection in London, UK.
Whitlock G, Carbonell M, Blackwell S, Nwokolo N; Dean Street Collaborative Group.
HIV Med. 2019 Nov;20(10):699-703. doi: 10.1111/hiv.12780.
https://www.medscape.com/viewarticle/920023
Seite 1 von 18